Literature DB >> 5335182

Riboflavine as an indicator of drug taking behaviour.

I H Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5335182     DOI： 10.5694/j.1326-5377.1967.tb21152.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  6 in total

1.  Assessment of drugs in schizophrenia. Basic trial design.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Measurement of patient compliance and the interpretation of randomized clinical trials.

Authors:  R Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The effect of glycopyrrolate on the course of symptomatic duodenal ulcer.

Authors:  H Trevino; J Anderson; P G Davey; K S Henley
Journal:  Am J Dig Dis       Date:  1967-10

4.  Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles.

Authors:  P Hungerbuhler; P Bovet; C Shamlaye; B Burnand; B Waeber
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

5.  Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial.

Authors:  Heather Ciliberto; Michael Ciliberto; Andreé Briend; Per Ashorn; Dennis Bier; Mark Manary
Journal:  BMJ       Date:  2005-04-25

6.  Controlled trial of amitriptyline in general practice.

Authors:  T G Blashki; R Mowbray; B Davies
Journal:  Br Med J       Date:  1971-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.